Page last updated: 2024-11-05

8-hydroxy-2-methylquinoline

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

8-hydroxy-2-methylquinoline is a heterocyclic compound that has been studied for its potential biological activities. It has been synthesized via a variety of methods, including the reaction of 2-methylquinoline with potassium permanganate or with nitric acid. The compound has been shown to exhibit antimicrobial and antioxidant properties. It has also been investigated for its potential as a corrosion inhibitor. The compound is important for its potential to inhibit the growth of bacteria and fungi, and for its ability to protect metal surfaces from corrosion. It is studied because of its potential applications in the fields of medicine, agriculture, and materials science.'

8-hydroxy-2-methylquinoline: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID13224
CHEMBL ID316892
CHEBI ID180510
SCHEMBL ID297247
MeSH IDM0396065

Synonyms (53)

Synonym
AC-12780
einecs 212-562-6
brn 0119194
hydroxyquinaldine
8-hydroxyqinaldine
nsc 58553
CHEMBL316892 ,
8-hydroxy quinaldine
7w631h5302 ,
unii-7w631h5302
ec 212-562-6
5-21-03-00341 (beilstein handbook reference)
CHEBI:180510
2-methyloxine
2-methyl-8-hydroxyquinoline
2-methyl-8-quinolinol
8-hydroxy-2-methylquinoline
nsc-58553
nsc58553
nsc-403349
8-quinolinol, 2-methyl-
inchi=1/c10h9no/c1-7-5-6-8-3-2-4-9(12)10(8)11-7/h2-6,12h,1h
826-81-3
2-methylquinolin-8-ol
2-methyl-oxine
8-hydroxyquinaldine
2-methyl-8-quinolinol, 98%
STK037617
HMS1647N13
M0420
2-methyl-quinolin-8-ol
bdbm50065785
AKOS000121472
NCGC00188188-01
AM804380
FT-0621549
FS-2928
hydroxy-2-methylquinoline, 8-
SCHEMBL297247
8-hydroxy-quinaldine
2-methyl 8-quinolinol
DTXSID3061184
W-104165
mfcd00006765
F0001-2119
8-hydroxyquinaldine; 8-hydroxy-2-methylquinoline
8-hydroxyquinaldine (8-hydroxy-2-methylquinoline)
CS-W004053
Q27268939
P20524
SB67453
EN300-17635
Z56969328

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
"8, but display excellent solubility at low pH, suggesting that oral dosing may be possible."( Identification of clinically viable quinolinol inhibitors of botulinum neurotoxin A light chain.
Barlow, DJ; Benoni, G; Bompiani, KM; Caglič, D; Dickerson, TJ; Houseknecht, KL; Krutein, MC; Lairson, LL; Pelletier, JC; Reitz, AB; Smith, GR, 2014
)
0.4
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
hydroxyquinoline
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (6)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
TDP1 proteinHomo sapiens (human)Potency7.07950.000811.382244.6684AID686978; AID686979
Smad3Homo sapiens (human)Potency19.95260.00527.809829.0929AID588855
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Botulinum neurotoxin type A Clostridium botulinumIC50 (µMol)16.95000.50003.16927.2000AID1068575; AID1434686
Methionine aminopeptidase 2Homo sapiens (human)IC50 (µMol)8.51500.00060.96835.6000AID1339157; AID760045
Methionine aminopeptidase 1Homo sapiens (human)IC50 (µMol)15.00008.10008.10008.1000AID1339156; AID760046
Integrase Human immunodeficiency virus 1IC50 (µMol)100.00000.00051.544310.0000AID599140; AID93509; AID93510
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (7)

Processvia Protein(s)Taxonomy
protein processingMethionine aminopeptidase 2Homo sapiens (human)
peptidyl-methionine modificationMethionine aminopeptidase 2Homo sapiens (human)
N-terminal protein amino acid modificationMethionine aminopeptidase 2Homo sapiens (human)
regulation of translationMethionine aminopeptidase 1Homo sapiens (human)
proteolysisMethionine aminopeptidase 1Homo sapiens (human)
peptidyl-methionine modificationMethionine aminopeptidase 1Homo sapiens (human)
N-terminal protein amino acid modificationMethionine aminopeptidase 1Homo sapiens (human)
protein maturationMethionine aminopeptidase 1Homo sapiens (human)
platelet aggregationMethionine aminopeptidase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (8)

Processvia Protein(s)Taxonomy
protein transmembrane transporter activityBotulinum neurotoxin type A Clostridium botulinum
RNA bindingMethionine aminopeptidase 2Homo sapiens (human)
aminopeptidase activityMethionine aminopeptidase 2Homo sapiens (human)
initiator methionyl aminopeptidase activityMethionine aminopeptidase 2Homo sapiens (human)
protein bindingMethionine aminopeptidase 2Homo sapiens (human)
metalloexopeptidase activityMethionine aminopeptidase 2Homo sapiens (human)
metal ion bindingMethionine aminopeptidase 2Homo sapiens (human)
metalloaminopeptidase activityMethionine aminopeptidase 2Homo sapiens (human)
aminopeptidase activityMethionine aminopeptidase 1Homo sapiens (human)
initiator methionyl aminopeptidase activityMethionine aminopeptidase 1Homo sapiens (human)
protein bindingMethionine aminopeptidase 1Homo sapiens (human)
metalloexopeptidase activityMethionine aminopeptidase 1Homo sapiens (human)
metal ion bindingMethionine aminopeptidase 1Homo sapiens (human)
metalloaminopeptidase activityMethionine aminopeptidase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (4)

Processvia Protein(s)Taxonomy
cytoplasmMethionine aminopeptidase 2Homo sapiens (human)
cytosolMethionine aminopeptidase 2Homo sapiens (human)
plasma membraneMethionine aminopeptidase 2Homo sapiens (human)
cytoplasmMethionine aminopeptidase 2Homo sapiens (human)
cytoplasmMethionine aminopeptidase 1Homo sapiens (human)
cytosolMethionine aminopeptidase 1Homo sapiens (human)
cytosolic ribosomeMethionine aminopeptidase 1Homo sapiens (human)
cytosolMethionine aminopeptidase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (35)

Assay IDTitleYearJournalArticle
AID1339155Inhibition of Rickettsia prowazekii str. Madrid E N-terminal His-tagged methionine aminopeptidase 1A expressed in Escherichia coli BL21(DE3) Rosetta cells using Met-AMC as substrate preincubated for 1 hr followed by substrate addition measured after 30 mi2017Bioorganic & medicinal chemistry, 02-01, Volume: 25, Issue:3
Rickettsia prowazekii methionine aminopeptidase as a promising target for the development of antibacterial agents.
AID566699Inhibition of mushroom tyrosinase at 1 mM after 10 mins2011Journal of medicinal chemistry, Jan-27, Volume: 54, Issue:2
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
AID1182519Radioprotective activity against gamma-irradiated human MOLT4 cells preincubated for 1 hr at 100 to 400 uM before gamma-irradiation measured after 18 hrs by erythrosine B dye-exclusion test2014Bioorganic & medicinal chemistry, Aug-01, Volume: 22, Issue:15
Design and synthesis of 8-hydroxyquinoline-based radioprotective agents.
AID566704Inhibition of human recombinant MMP3 at 1 mM after 30 mins2011Journal of medicinal chemistry, Jan-27, Volume: 54, Issue:2
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
AID566701Inhibition of recombinant anthrax lethal factor at 1 mM after 30 mins by fluorescence assay2011Journal of medicinal chemistry, Jan-27, Volume: 54, Issue:2
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
AID566707Inhibition of mouse recombinant iNOS at 1 mM after 40 mins by colorimetric assay2011Journal of medicinal chemistry, Jan-27, Volume: 54, Issue:2
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
AID1268192Drug level in HEPES buffer treated with 50 uM (S)-2-methylquinolin-8-yl 3-(2-amino-4-methylpentanamido)propane-1-sulfonate in presence of aeromonas proteolytica aminopeptidase by spectrophotometry2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Development of a novel sulfonate ester-based prodrug strategy.
AID93509In vitro anti-HIV integrase activity against 3' processing of target plasmid.1998Journal of medicinal chemistry, Jul-16, Volume: 41, Issue:15
Styrylquinoline derivatives: a new class of potent HIV-1 integrase inhibitors that block HIV-1 replication in CEM cells.
AID1339160Antibacterial activity against Rickettsia prowazekii str. Breinl infected in CD rat primary pulmonary vascular endothelial cells assessed as protection against bacterial infection by measuring restoration of host cell viability at 0.003 to 3 uM measured 72017Bioorganic & medicinal chemistry, 02-01, Volume: 25, Issue:3
Rickettsia prowazekii methionine aminopeptidase as a promising target for the development of antibacterial agents.
AID1268177Drug level in HEPES buffer treated with 2 mM (S)-2-methylquinolin-8-yl 3-(2-amino-4-methylpentanamido)propane-1-sulfonate for 12 hrs in presence of aeromonas proteolytica aminopeptidase by spectrophotometry2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Development of a novel sulfonate ester-based prodrug strategy.
AID1824261Inhibition of recombinant NDM-1 (unknown origin) using fluorocillin as substrate at 10 uM incubated for 30 mins by fluorescence based assay2022European journal of medicinal chemistry, Jan-15, Volume: 228Nitroxoline and its derivatives are potent inhibitors of metallo-β-lactamases.
AID760045Inhibition of human methionine aminopeptidase 22013ACS medicinal chemistry letters, Jul-01, Volume: 4, Issue:8
Discovery of Inhibitors of
AID1434686Inhibition of protease activity of recombinant full length Clostridium botulinum Hall BoNT/A light chain using SNAP-25 peptide (187 to 203 residues) as substrate after 5 mins by HPLC analysis2017Bioorganic & medicinal chemistry letters, 02-01, Volume: 27, Issue:3
A matrix-focused structure-activity and binding site flexibility study of quinolinol inhibitors of botulinum neurotoxin serotype A.
AID727213Cytotoxicity against human K562 cells at 50 ug/ml after 48 hrs by MTS assay relative to control2013ACS medicinal chemistry letters, Feb-14, Volume: 4, Issue:2
Synthesis of 8-hydroxyquinoline derivatives as novel antitumor agents.
AID1268179Drug level in human serum treated with 5 mM (S)-2-methylquinolin-8-yl 3-(2-amino-4-methylpentanamido)propane-1-sulfonate after 24 hrs by HPLC analysis2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Development of a novel sulfonate ester-based prodrug strategy.
AID1068575Inhibition of Clostridium botulinum BoNT/A LC expressed in Escherichia coli assessed as cleavage of SNAPtide preincubated for 5 mins followed by SNAPtide addition measured for 105 mins by fluorescence assay2014Journal of medicinal chemistry, Feb-13, Volume: 57, Issue:3
Identification of clinically viable quinolinol inhibitors of botulinum neurotoxin A light chain.
AID760047Inhibition of Burkholderia pseudomallei recombinant methionine aminopeptidase 1 using H-Met-Gly-Pro-7-amino-4-methylcoumarin hydrochloride as substrate measured for 10 mins by fluorescence assay in presence of human recombinant DPP42013ACS medicinal chemistry letters, Jul-01, Volume: 4, Issue:8
Discovery of Inhibitors of
AID1268203Retention time of compound by HPLC analysis2016Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2
Development of a novel sulfonate ester-based prodrug strategy.
AID1339157Inhibition of recombinant full length human N-terminal GST/His6-tagged methionine aminopeptidase 2 expressed in baculovirus infected sf9 cells using methionylprolyl-p-nitroanilide as substrate preincubated for 20 mins followed by substrate addition measur2017Bioorganic & medicinal chemistry, 02-01, Volume: 25, Issue:3
Rickettsia prowazekii methionine aminopeptidase as a promising target for the development of antibacterial agents.
AID566703Inhibition of human recombinant MMP2 at 1 mM after 30 mins2011Journal of medicinal chemistry, Jan-27, Volume: 54, Issue:2
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
AID566702Inhibition of human recombinant MMP1 at 1 mM after 30 mins2011Journal of medicinal chemistry, Jan-27, Volume: 54, Issue:2
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
AID566706Inhibition of human recombinant MMP9 at 1 mM after 30 mins2011Journal of medicinal chemistry, Jan-27, Volume: 54, Issue:2
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
AID1339156Inhibition of recombinant full length human His-tagged methionine aminopeptidase 1 expressed in Escherichia coli BL21(DE3) using methionylprolyl-p-nitroanilide as substrate preincubated for 20 mins followed by substrate addition measured for 20 mins in pr2017Bioorganic & medicinal chemistry, 02-01, Volume: 25, Issue:3
Rickettsia prowazekii methionine aminopeptidase as a promising target for the development of antibacterial agents.
AID566700Inhibition of human recombinant 5-lipoxygenase at 1 mM after 10 mins by fluorescence assay2011Journal of medicinal chemistry, Jan-27, Volume: 54, Issue:2
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
AID727214Cytotoxicity against human T47D cells at 50 ug/ml after 48 hrs by MTS assay relative to control2013ACS medicinal chemistry letters, Feb-14, Volume: 4, Issue:2
Synthesis of 8-hydroxyquinoline derivatives as novel antitumor agents.
AID1824260Inhibition of recombinant NDM-1 (unknown origin) using fluorocillin as substrate at 30 uM incubated for 30 mins by fluorescence based assay2022European journal of medicinal chemistry, Jan-15, Volume: 228Nitroxoline and its derivatives are potent inhibitors of metallo-β-lactamases.
AID599140Inhibition of HIV1 integrase 3' processing activity2008European journal of medicinal chemistry, Jan, Volume: 43, Issue:1
Exploring molecular shape analysis of styrylquinoline derivatives as HIV-1 integrase inhibitors.
AID93510In vitro anti-HIV integrase activity against integration (strand transfer) of target plasmid.1998Journal of medicinal chemistry, Jul-16, Volume: 41, Issue:15
Styrylquinoline derivatives: a new class of potent HIV-1 integrase inhibitors that block HIV-1 replication in CEM cells.
AID760046Inhibition of human methionine aminopeptidase 12013ACS medicinal chemistry letters, Jul-01, Volume: 4, Issue:8
Discovery of Inhibitors of
AID1339164Cytotoxicity against CD rat primary pulmonary vascular endothelial cells assessed as reduction in cell viability at 0.003 to 3 uM measured after 72 hrs by WST1 assay2017Bioorganic & medicinal chemistry, 02-01, Volume: 25, Issue:3
Rickettsia prowazekii methionine aminopeptidase as a promising target for the development of antibacterial agents.
AID566705Inhibition of human recombinant MMP8 at 1 mM after 30 mins2011Journal of medicinal chemistry, Jan-27, Volume: 54, Issue:2
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
AID760043Antibacterial activity against Burkholderia thailandensis E264 assessed as bacterial growth inhibition at 1 mM after 24 hrs by two-fold dilution method relative to DMSO-treated control2013ACS medicinal chemistry letters, Jul-01, Volume: 4, Issue:8
Discovery of Inhibitors of
AID1824262Inhibition of recombinant NDM-1 (unknown origin) using fluorocillin as substrate at 3 uM incubated for 30 mins by fluorescence based assay2022European journal of medicinal chemistry, Jan-15, Volume: 228Nitroxoline and its derivatives are potent inhibitors of metallo-β-lactamases.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (28)

TimeframeStudies, This Drug (%)All Drugs %
pre-199012 (42.86)18.7374
1990's1 (3.57)18.2507
2000's3 (10.71)29.6817
2010's11 (39.29)24.3611
2020's1 (3.57)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 20.94

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index20.94 (24.57)
Research Supply Index3.43 (2.92)
Research Growth Index5.08 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (20.94)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other30 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]